Objective: To analyze the clinical features of 6 patients with primary aldosteronism(PA), the results of adrenal venous sampling(AVS), and the application value of two PA subtyping predictive scoring systems in order to improve the understanding, diagnosis and treatment of the disease among clinicians. Methods: The general clinical data, diagnosis and treatment of 6 patients diagnosed with PA and underwent AVS in Nanjing Lishui People's Hospital from March 2022 to April 2023 were retrospectively analyzed, and the application value of SPACE and CLR scoring systems were evaluated combined with published papers. Results: All the 6 patients with an average age of 50 years presented with hypertension, and 4 of the 6 with hypokalemia. The upright plasma aldosterone-to-renin ratio(ARR) in all patients exceeded the usual cut-off point, the confirmatory tests were positive, and the success rate of bilateral AVS was 50%. Along with 10 cases published in China in the past 5 years, the SPACE scoring system displayed a positive/negative predictive value of 100%/50%, avoiding AVS in 41.6%of patients. The agreement rate of CLR and SPACE scoring system in predicting PA subtyping was 75%. Conclusion: For patients with PA, if AVS is unavailable or of unilateral success, the SPACE or CLR scoring systems can be integrated in clinical practice to enable some patients to be properly treated in the cases of avoiding initial or repetitive AVS. |
[1] REINCKE M,BANCOS I,MULATERO P,et al.Diagnosis and treatment of primary aldosteronism[J].Lancet Diabetes Endo,2021,9(12):876-892.
[2] WILLIAMS T A,REINCKE M.Pathophysiology and histopathology of primary aldosteronism[J].Trends Endocrinol Metab,2022,33(1):36-49.
[3] 中华医学会内分泌学分会.原发性醛固酮增多症诊断治疗的专家共识(2020版)[J].中华内分泌代谢杂志,2020,36(9):727-736.
[4] 苗新宇,陈康,曾正陪.肾上腺静脉采血在原发性醛固酮增多症诊治中的历史、现状与争议[J].中华内科杂志,2022,61(10):1085-1090.
[5] BURRELLO J,BURRELLO A,PIERONI J,et al.Development and validation of prediction models for subtype diagnosis of patients with primary aldosteronism[J].J Clin Endocrinol Metab,2020,105(10):dgaa379.
[6] BURRELLO J,BURRELLO A,PIERONI J,et al.Prediction of hyperaldosteronism subtypes when adrenal vein sampling is unilaterally successful[J].Eur J Endocrinol,2020,183(6):657-667.
[7] NG E,GWINI S M,LIBIANTO R,et al.Aldosterone,renin,and aldosterone-to-renin ratio variability in screening for primary aldosteronism[J].J Clin Endocrinol Metab,2022,108(1):33-41.
[8] STOWASSER M,AHMED A H,COWLEY D,et al.Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism[J].J Clin Endocrinol Metab,2018,103(11):4113-4124.
[9] LIU B,HU J,SONG Y,et al.Seated saline suppression test is comparable with captopril challenge test for the diagnosis of primary aldosteronism:a prospective study[J].Endocr Pract,2021,27(4):326-333.
[10] SONG Y,YANG S,HE W,et al.Confirmatory tests for the diagnosis of primary aldosteronism:a prospective diagnostic accuracy study[J].Hypertension,2018,71(1):118-124.
[11] WILLIAMS T A,BURRELLO J,SECHI L A,et al.Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism[J].Hypertension,2018,72(3):641-649.
[12] OHNO Y,NARUSE M,BEUSCHLEIN F,et al.Adrenal venous sampling-guided adrenalectomy rates in primary aldosteronism:results of an international cohort(AVSTAT)[J].J Clin Endocrinol Metab,2021,106(3):e1400-e1407.
[13] 董徽,蒋雄京,彭猛,等.经肘正中静脉行分侧肾上腺静脉取血的可行性与安全性研究:附50例首次报告[J].中华高血压杂志,2016,24(2):158-162.
[14] LIU W,ZHANG J,YANG Y,et al.Effect of adrenocorticotropic hormone stimulation during simultaneous bilateral adrenal vein sampling in primary aldosteronism[J].Horm Metab Res,2021,53(6):364-370.
[15] KVPERS E M,AMAR L,RAYNAUD A,et al.A clinical prediction score to diagnose unilateral primary aldosteronism[J].J Clin Endocrinol Metab,2012,97(10):3530-3537.
[16] ZHANG Y,NIU W,ZHENG F,et al.Identifying unilateral disease in Chinese patients with primary aldosteronism by using a modified prediction score[J].J Hypertens,2017,35(12):2486-2492. |